You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Novel Single-Agent Immunotherapies
1403-B Sonata’s proprietary intrinsic antigen release technology (iART) drives in situ generation of potent anti-tumor immunity across warm and cold tumor models

 

Online download statistics by month:

Online download statistics by month: December 2023 to June 2025

AbstractFullPdf
Dec 20232807
Jan 20243800
Feb 20244605
Mar 20242403
Apr 20246008
May 20244003
Jun 20243200
Jul 20242401
Aug 20243408
Sep 20242803
Oct 20243805
Nov 20242406
Dec 20245408
Jan 20251606
Feb 20251107
Mar 20250019
Apr 2025004
May 2025008
Jun 2025003
Total4970104